Arsenic trioxide combined with dasatinib (Src and BCR-ABL inhibitor) synergistically inhibited the proliferation and induced apoptosis of Philadelphia chromosome-positive (Ph+) ALL cells (SUP-B15) and negative ALL cells (TOM-1). Here, SRC is linked to acute lymphoblastic leukemia.